Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda RolloutMerck plans to launch a subcutaneous Keytruda for cancer treatment in the US, awaiting FDA approval by September 23.
Man Loses Most of His Penis After Filler Procedure—Doctor Blames the PatientIn a harrowing tale that has caught the attention of many, a man faced devastating consequences after undergoing a penile filler procedure.
Top 10 Essential Shots You Need Beyond COVID-19Don't forget non-COVID vaccines! Protect against diseases like Hepatitis B, Cervical Cancer, and Meningococcal Infection.
Must-Reads
1
Arrest warrants issued for 48 suspects brought from Cambodia
LATEST
2
S. Korea's exports down 7.8% in first 20 days of Oct.
LATEST
3
S. Korean man found dead in Cambodia: foreign ministry
LATEST
4
Remains of late S. Korean student tortured to death in Cambodia arrive home
LATEST
5
Trump expects 'fantastic' trade deal with China, notes 'fair' deals with S. Korea, Japan, EU
Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout Merck plans to launch a subcutaneous Keytruda for cancer treatment in the US, awaiting FDA approval by September 23.
Man Loses Most of His Penis After Filler Procedure—Doctor Blames the Patient In a harrowing tale that has caught the attention of many, a man faced devastating consequences after undergoing a penile filler procedure.
Top 10 Essential Shots You Need Beyond COVID-19 Don't forget non-COVID vaccines! Protect against diseases like Hepatitis B, Cervical Cancer, and Meningococcal Infection.
Hot Topics